Position：Executive Vice Chair of Pharmacy
Department：Pharmacy
Medical School：Zhejiang University School of Medicine, China
Academic Rank：Chief Pharmacist
Hospital pharmacy, sustained and/or controlled release, clinical pharmacokinetics, pharmacogenomics, molecular pharmaceutics.
Senior Member, Chinese Pharmaceutical Association
Member, Chinese Pharmacological Association
Dr. Xu has published more than 80 research articles or reviews, including 5 SCI papers as first author or corresponding author.
Xu DH, et al. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance. Pharm Dev Technol. 2020 Oct 18:1-9. (Correspond author)
Xu DH, et al. Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models. Mol Pharm. 2020 Feb 3;17(2):499-506. (Correspond author)
Xu DH, et al. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells. Drug Dev Ind Pharm. 2019 Sep;45(9):1556-1564. (Correspond author)
88 Jiefang Road,Shangcheng District Hangzhou,China, 310009
1511 Jianghong Road,Binjiang District Hangzhou,China, 310014
300 Yuanju Road, Shangcheng DIstrict, Hangzhou
456 Qidi Road, Xiaoshan District, Hangzhou, China
1 Xihu Avenue, Shangcheng District, Hangzhou
Zijingang Campus of Zhejiang University, 866 Yuhangtang Road, Xihu District, Hangzhou
Please call +86-571-8971 3988 (8am-5pm, Monday through Friday)
Make an appointment online
The Second Affiliated Hospital
Zhejiang University School of Medicine
88 Jiefang Road, Hangzhou, China
+86-571-8731 5108
iao_sahzu@zju.edu.cn
The Needs of Patients and Customers Come First.
The Second Affiliated Hospital Zhejiang University School of Medicine
All Rights Reserved.
